William Conkling Rafael Holdings, Inc. (RFL) insider trading activity

William Conkling is Chief Executive Officer of Rafael Holdings, Inc.. Currently has a direct ownership of 504,622 shares of RFL, which is worth approximately $913,365. The most recent transaction as insider was on Oct 25, 2024, when has been sold 3,431 shares (Class B Common Stock, par value $.01 per share) at a price of $1.84 per share, resulting in proceeds of $6,313. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 505K

3.1% 3M change

10.39% 12M change

Total Value Held $913,365

WILLIAM CONKLING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 25 2024	SELL Payment of exercise price or tax liability	$6,313 $1.84 p/Share	3,431 Reduced 0.68%	504,622 Class B Common Stock, ...
Sep 21 2024	SELL Payment of exercise price or tax liability	$21,964 $1.73 p/Share	12,696 Reduced 2.44%	508,053 Class B Common Stock, ...
Jun 21 2024	SELL Payment of exercise price or tax liability	$19,410 $1.46 p/Share	13,295 Reduced 2.49%	520,749 Class B Common Stock, ...
Mar 21 2024	BUY Payment of exercise price or tax liability	$26,304 $1.7 p/Share	15,473 Added 2.82%	534,044 Class B Common Stock, ...
Dec 21 2023	BUY Payment of exercise price or tax liability	$24,755 $1.82 p/Share	13,602 Added 2.42%	549,517 Class B Common Stock, ...
Oct 25 2023	BUY Grant, award, or other acquisition	$60,400 $1.51 p/Share	40,000 Added 6.63%	563,119 Class B Common Stock, ...
Sep 21 2023	SELL Payment of exercise price or tax liability	$30,208 $2.21 p/Share	13,669 Reduced 2.55%	523,119 Class B Common Stock, ...
Jun 21 2023	SELL Payment of exercise price or tax liability	$32,615 $2.15 p/Share	15,170 Reduced 2.75%	536,788 Class B Common Stock, ...
Mar 21 2023	SELL Payment of exercise price or tax liability	$26,093 $1.67 p/Share	15,625 Reduced 2.75%	551,958 Class B Common Stock, ...
Dec 21 2022	SELL Payment of exercise price or tax liability	$98,822 $1.76 p/Share	56,149 Reduced 9.0%	567,583 Class B Common Stock, ...
Feb 01 2022	BUY Grant, award, or other acquisition	-	623,732 Added 50.0%	623,732 Class B Common Stock, ...

Also insider at

CYTH

Cyclo Therapeutics, Inc. Healthcare

Director